Digoxin Tablet
Product Images NDC 70518-3859

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Digoxin (NDC 70518-3859). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Digoxin 0.125 mg oral tablets packaging label displaying the product name, strength, dosage form, and quantity of 30 tablets. The label also indicates the labeler as RemedyRepack Inc., includes a barcode, QR code, and manufacturer information (Aurobindo, India). Directions reference the package insert with storage instructions.*

FDA Label Image

Chemical Structure (Digoxin Str)

Chemical structure diagram of the active ingredient Digoxin, showing the molecular components and bonding arrangements typical of this cardiac glycoside.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.